Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Giulio Rossi, Alberto Cavazza, Paolo Spagnolo, Salvatore Bellafiore, Elisabetta Kuhn, Pierpaolo Carassai, Laura Caramanico, Gloria Montanari, Gaia Cappiello, Alessandro Andreani, Francesca Bono, Nazarena Nannini. The role of macrophages in interstitial lung diseases. Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017

Member's Comments

No comment yet.

Related content which might interest you: A crucial role for lung interstitial macrophages in preventing airway allergy Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019 Year: 2020 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Interstitial lung diseases and systemic disorders with lung involvement Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 Interstitial lung diseases and systemic disorders with lung involvement Source: ERS Skills Course 2016 Year: 2016 Key role of osteopontin in smoking-related interstitial lung diseases Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019 Interstitial lung diseases in infants and children Source: Eur Respir J 2008; 31: 658-666 Year: 2008 CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases Source: Eur Respir J, 55 (2) 1900460; 10.1183/13993003.00460-2019 Year: 2020 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease Source: Eur Respir Monogr 2022; 95: 219-237 Year: 2022 Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Increased BALF eosinophils and underlying interstitial lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The lung epithelial clock and its role in lung inflammation Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions Year: 2017 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002